Goodwin Procter LLP and Cooley LLP advised I-Mab on the deal. I-Mab (Nasdaq: IMAB) announced its broad, global collaboration with AbbVie (NYSE: ABBV) for the development and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
